The Food and Drug Administration’s new approach to personalized medicine was sent in motion on
Zecola explains that such an approach is misguided for several reasons:
1) The provision of personal genetic information is just that, an information service. The FTC, not the
2) The action is paternalistic and impinges upon personal liberty. The personal genetics companies include disclaimers on their websites and materials saying that their customers should not take action on the personal genetic information but rather should consult with a certified healthcare practitioner before taking any action.
3) The FDA’s action, in effect, protects the status quo and undermines the potential for innovation in personalized medicine.
Zecola argues that rather than protecting the status quo from new technology, the
In essence, the burden should be on the
The article is available at http://www.TheFDAandYou.com.
For additional work by the author describing how government should better manage science and technology, see “The Major Forces Driving Humanity: Solutions for a Growing Divide” (2008). Also see “Obama Needs Better Tools to Drive Lasting Change” (
Read the full story at http://www.prweb.com/releases/2014/01/prweb11477571.htm
Most Popular Stories
- SoCalGas Reaches Record Spend on Diversity Suppliers
- Menendez Introduces Tough Sanctions Against Russia
- Republican Jolly Wins Fla. Special Election
- World Wide Web Turns 25
- Senate Dems Pull All-Nighter on Global Warming
- Obama Seeks Overtime Pay for Salaried Workers
- Clarke Replaces Perez at Eastman Kodak
- Vestas Ramps Up Hiring to Build Wind Turbines
- Copper Plunges on China Jitters
- Jan Brewer Out on Term Limits